British lab taps Nucletron radiotherapy technology

The National Physical Laboratory (NPL), a national measurement institute in Teddington, England, has purchased a Flexitron afterloader from Nucletron, an Elekta company.

NPL will continue to offer its brachytherapy calibration service with the new afterloader, and ensure source calibrations in radiotherapy centers remain traceable to NPL's primary standard. Veenendaal, The Netherlands-based Nucletron and NPL have collaborated since 1992.

Flexitron is designed to treat both very small and very large tumors without reconnections, in 1 mm steps, according to NPL. Determination of source positions is enhanced with Nucletron's reference source positioning system, which defines dwell positions in absolute values.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup